Government response to the third addendum to the Advisory Council on the Misuse of Drugs’ report on 2-benzyl benzimidazole and piperidine benzimidazolone opioids.



Documents

Government response to the third addendum to the ACMD’s report on 2-benzyl benzimidazole and piperidine benzimidazolone opioids

HTML

Details

Government response to the third addendum to the Advisory Council on the Misuse of Drugs’ report on 2-benzyl benzimidazole and piperidine benzimidazolone opioids.

Published 21 March 2024